Site Members can sign up for company wide alerts
Investigation Overview
February 22, 2017 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Zeltiq Aesthetics Inc (NASDAQ:ZLTQ), was announced concerning whether the takeover of Zeltiq Aesthetics Inc by Allergan plc for $56.50 per share is unfair to NASDAQ:ZLTQ stockholders. The investigation by a law firm concerns whether certain officers and directors of Zelt...
You must register (for free) or login to view the entire investigation.